Can antibody infusions shield CLL patients from deadly infections?

NCT ID NCT04502030

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether regular infusions of Panzyga (a concentrated antibody solution from donated blood) could prevent serious infections in people with chronic lymphocytic leukemia (CLL) who also have low antibody levels. The trial included 247 adults with CLL who were receiving cancer treatment. Half got Panzyga, half got a placebo. The goal was to see if Panzyga reduced the number of major infections requiring hospitalization or leading to death.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Panzyga (a human antibody solution given intravenously)

What this could lead to

If it works, this could give CLL patients a way to prevent serious infections while on cancer treatment.

What could go wrong

This is a completed Phase 3 trial, but results are not yet published. The benefit may be modest, and IVIG infusions can cause side effects like headache, fever, or allergic reactions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agammaglobulinemia B-cell chronic lymphocytic leukemia syndromic agammaglobulinemia infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Octapharma Research Site

    St. Petersburg, Florida, 33709, United States

  • Octapharma Research Site

    Columbus, Georgia, 31904, United States

  • Octapharma Research Site

    Macon, Georgia, 31201, United States

  • Octapharma Research Site

    New Orleans, Louisiana, 70112, United States

  • Octapharma Research Site

    Baltimore, Maryland, 21201, United States

  • Octapharma Research Site

    Baltimore, Maryland, 21205, United States

  • Octapharma Research Site

    Detroit, Michigan, 48093, United States

  • Octapharma Research Site

    Rochester, Minnesota, 55902, United States

  • Octapharma Research Site

    Buffalo, New York, 14260, United States

  • Octapharma Research Site

    New York, New York, 10032, United States

  • Octapharma Research Site

    New York, New York, 10065, United States

  • Octapharma Research Site

    Shirley, New York, 11967, United States

  • Octapharma Research Site

    Durham, North Carolina, 27710, United States

  • Octapharma Research Site

    Charleston, South Carolina, 29414, United States

  • Octapharma Research Site

    Houston, Texas, 77090, United States

  • Octapharma Research Site

    Brno, 625 00, Czechia

  • Octapharma Research Site

    Hradec Králové, 500 05, Czechia

  • Octapharma Research Site

    Ostrava, 70852, Czechia

  • Octapharma Research Site

    Aalborg, 9000, Denmark

  • Octapharma Research Site

    Herning, 7400, Denmark

  • Octapharma Research Site

    Roskilde, 4000, Denmark

  • Octapharma Research Site

    Dortmund, 44263, Germany

  • Octapharma Research Site

    Frankfurt, 15236, Germany

  • Octapharma Research Site

    Kiel, 24105, Germany

  • Octapharma Research Site

    Marburg, 35037, Germany

  • Octapharma Research Site

    Athens, 10676, Greece

  • Octapharma Research Site

    Athens, 11526, Greece

  • Octapharma Research Site

    Athens, 12462, Greece

  • Octapharma Research Site

    Ioannina, 45500, Greece

  • Octapharma Research Site

    Pátrai, 26500, Greece

  • Octapharma Research Site

    Thessaloniki, 57010, Greece

  • Octapharma Research Site

    Budapest, 1088, Hungary

  • Octapharma Research Site

    Debrecen, 4032, Hungary

  • Octapharma Research Site

    Győr, 9023, Hungary

  • Octapharma Research Site

    Kaposvár, 7400, Hungary

  • Octapharma Research Site

    Nyíregyháza, 4400, Hungary

  • Octapharma Research Site

    Haifa, 3109601, Israel

  • Octapharma Research Site

    Haifa, 34362, Israel

  • Octapharma Research Site

    Petah Tikva, 49100, Israel

  • Octapharma Research Site

    Castelfranco Veneto, 31033, Italy

  • Octapharma Research Site

    Milan, 20132, Italy

  • Octapharma Research Site

    Milan, 20162, Italy

  • Octapharma Research Site

    Modena, 41124, Italy

  • Octapharma Research Site

    Orbassano, 10043, Italy

  • Octapharma Research Site

    Padova, 35129, Italy

  • Octapharma Research Site

    Pescara, 65124, Italy

  • Octapharma Research Site

    Reggio Calabria, 89133, Italy

  • Octapharma Research Site

    Rome, 00161, Italy

  • Octapharma Research Site

    Torino, 10126, Italy

  • Octapharma Research Site

    Bialystok, 15-732, Poland

  • Octapharma Research Site

    Bydgoszcz, 85-065, Poland

  • Octapharma Research Site

    Gdansk, 80-214, Poland

  • Octapharma Research Site

    Gdansk, 80-219, Poland

  • Octapharma Research Site

    Gdynia, 81-519, Poland

  • Octapharma Research Site

    Katowice, 40-519, Poland

  • Octapharma Research Site

    Legnica, 59-220, Poland

  • Octapharma Research Site

    Lodz, 93-513, Poland

  • Octapharma Research Site

    Torun, 87-100, Poland

  • Octapharma Research Site

    Warsaw, 02-776, Poland

  • Octapharma Research Site

    Wroclaw, 50-367, Poland

  • Octapharma Research Site

    Barnaul, 656024, Russia

  • Octapharma Research Site

    Kemerovo, 650066, Russia

  • Octapharma Research Site

    Moscow, 115478, Russia

  • Octapharma Research Site

    Moscow, 125284, Russia

  • Octapharma Research Site

    Nizhny Novgorod, 603126, Russia

  • Octapharma Research Site

    Novosibirsk, 630051, Russia

  • Octapharma Research Site

    Petrozavodsk, 185019, Russia

  • Octapharma Research Site

    Rostov-on-Don, 344037, Russia

  • Octapharma Research Site

    Saint Petersburg, 191024, Russia

  • Octapharma Research Site

    Samara, 443079, Russia

  • Octapharma Research Site

    Tomsk, 634063, Russia

  • Octapharma Research Site

    Tula, 300053, Russia

  • Octapharma Research Site

    Ufa, 450008, Russia

  • Octapharma Research Site

    Yekaterinburg, 620102, Russia

  • Octapharma Research Site

    Madrid, 28034, Spain

  • Octapharma Research Site

    Madrid, 28040, Spain

  • Octapharma Research Site

    Madrid, 28046, Spain

  • Octapharma Research Site

    Oviedo, 33011, Spain

  • Octapharma Research Site

    Santander, 39008, Spain

  • Octapharma Research Site

    Ankara, 65900, Turkey (Türkiye)

  • Octapharma Research Site

    Antalya, 7050, Turkey (Türkiye)

  • Octapharma Research Site

    Istanbul, 34093, Turkey (Türkiye)

  • Octapharma Research Site

    Izmir, 35100, Turkey (Türkiye)

  • Octapharma Research Site

    Kayseri, 38039, Turkey (Türkiye)